ESMO 2022 Conference Coverage

 

ESMO 2022 Conference Coverage
M

Lecture Summary - ESMO 2022 on the Phase 4 KEYNOTE-B10 Study: Pembro + Carbo + Paclitaxel as 1L Therapy in Recurrent/Metastatic HNSCC

By ESMO 2022 Conference Coverage FEATURING Marcin Dzienis
By ESMO 2022 Conference Coverage FEATURING Marcin Dzienis
2 views
September 30, 2022
0 Comments
Login to view comments. Click here to Login
Head and Neck
03:03
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on the IT-MATTERS Study: Early Response …

Feat. P. Lavin
14:06
ESMO 2022 Conference Coverage

ESMO 2022 on the IT-MATTERS Study: Early Response to Leukocyte Inter…

Feat. P. Lavin
10:16
ESMO 2022 Conference Coverage

ESMO 2022 H&N Updates

Feat. N. Saba
48
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on the Phase 4 KEYNOTE-B10 Study: Pembro…

Feat. M. Dzienis
06:12
ESMO 2022 Conference Coverage

ESMO 2022 on the Phase 4 KEYNOTE-B10 Study: Pembro + Carbo + Paclita…

Feat. M. Dzienis
06:03
ESMO 2022 Conference Coverage

ESMO 2022: Contemporary Approach to the Multidisciplinary Management…

Feat. P. Bossi
35
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 Updates on the Randomized Phase III VANC…

Feat. H. Chong Toh
10:12
ESMO 2022 Conference Coverage

ESMO 2022 Updates on the Randomized Phase III VANCE Study: Gem &…

Feat. H. Chong Toh
01:48
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on Multi-Omic Profiling in H&N Cance…

Feat. I. Tinhofer
17:08
ESMO 2022 Conference Coverage

ESMO 2022 on Multi-Omic Profiling in H&N Cancer: Clinical Applic…

Feat. I. Tinhofer
05:46
ESMO 2022 Conference Coverage

ESMO 2022: NGS Helps Predict Response to IO in Recurrent/Metastatic …

Feat. O. Mirallas
05:19
ESMO 2022 Conference Coverage

ESMO 2022 Evaluation of the DNA Damage Response Network as a Predict…

Feat. P. Oikonomopoulou
04:03
ESMO 2022 Conference Coverage

ESMO 2022 on the EPOCKS Study: Exclusive CRT & Surgery or Induct…

Feat. J. Fayette
05:50
ESMO 2022 Conference Coverage

ESMO 2022 Liquid Biopsy for Detection of Molecular Residual Disease …

Feat. S. Flach